Back to top

Image: Bigstock

Top Ranked Income Stocks to Buy for July 22nd

Read MoreHide Full Article

Here are four stocks with buy rank and strong income characteristics for investors to consider today, July 22nd:

The Buckle, Inc. (BKE - Free Report) : This retailer of casual apparel and footwear has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 5%, compared with the industry average of 0%. Its five-year average dividend yield is 4%.

Buckle, Inc. (The) Dividend Yield (TTM)

Buckle, Inc. (The) Dividend Yield (TTM)

Buckle, Inc. (The) dividend-yield-ttm | Buckle, Inc. (The) Quote

Kimberly-Clark Corporation (KMB - Free Report) : This personal care products manufacturer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 3%, compared with the industry average of 0%. Its five-year average dividend yield is 3.2%.

Compass Minerals International, Inc. (CMP - Free Report) : This producer of salt and chemical products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 5.2%, compared with the industry average of 2%. Its five-year average dividend yield is 4%.

Sinopec Shanghai Petrochemical Company Limited (SHI - Free Report) : This petrochemical products manufacturer has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.7% over the last 60 days.

This Zacks Rank #1 company has a dividend yield of 9%, compared with the industry average of 2%. Its five-year average dividend yield is 3.8%.

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>